Type 2 Diabetes Clinical Trial
Official title:
The Alberta Diet: a Proposal for Its Implementation
| Verified date | July 2015 |
| Source | University of Alberta |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Canada: Ethics Review Committee |
| Study type | Interventional |
The study hypothesis is that individuals with type 2 diabetes (T2D), who adhere to the PANDA intervention, will have improved compliance with the nutritional therapy recommendations of the Canadian Diabetes Association. Specific objectives of this proposal: The objectives of the investigators PANDA (Physical Activity and Nutrition for Diabetes in Alberta) are to (a) to devise and evaluate the efficacy of a multi-level, practical, nutrition intervention program that promotes the individual factors required for effective self-management practices AND that explicitly incorporate strategies to improve food availability, accessibility and acceptability and (b) to use these interventions as a means to examine the relationships between food availability, accessibility, acceptability, adherence to Nutrition Therapy Guidelines, and metabolic indicators of diabetes control in people with type 2 diabetes.
| Status | Completed |
| Enrollment | 73 |
| Est. completion date | December 2013 |
| Est. primary completion date | October 2013 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 35 Years to 80 Years |
| Eligibility |
Inclusion Criteria: - Type 2 diabetes, and speak/write English. - Have attended a diabetes education session delivered by their healthcare provider. Exclusion Criteria: - Participants with type 1 diabetes, and those who are unable to speak English. - People with end-stage renal disease or gastrointestinal diseases that require specialized diets will also be excluded. |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| Canada | Alberta Diabetes Institute | Edmonton | Alberta |
| Lead Sponsor | Collaborator |
|---|---|
| University of Alberta |
Canada,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in Total Energy Intake | Measured using repeated 24 hour dietary recalls (pre and post-intervention) | 4 months | No |
| Primary | Change in Macronutrient Intake | Measured using repeated 24 hour dietary recalls (pre and post-intervention) | 3 months | No |
| Primary | Change in Nutrient Intake | Measured using repeated 24 hour dietary recalls (pre and post-intervention) | 3 months | No |
| Secondary | Change in Hemoglobin A1c | a surrogate of blood glucose control | 4 months | No |
| Secondary | Program Retention | attendance at meetings | 3 months | No |
| Secondary | Change in Body Mass Index | Actual weight and height used to calculate BMI pre- and post-intervention | 4 months | No |
| Secondary | Body Composition | body fat and fat-free mass | 3 months | No |
| Secondary | Change in Blood Biomarkers | blood lipids: triglyceride, total cholesterol, LDL-cholesterol, HDL-cholesterol | 4 months | No |
| Secondary | Change in Perceived Dietary Adherence Questionnaire Score | Questionnaire assessing self-reported adherence to 9 criteria, whose individual scores (range 0-7) are summed to get the total score. Maximum total score is 63. Minimum total score is 0. A higher score means higher dietary adherence. | 4 months | No |
| Secondary | Food Acceptability | questionnaire based on items related to personal and cultural acceptability of the recommended diet | 4 months | No |
| Secondary | Food Accessibility | questionnaire of items related to financial and physical accessibility of foods in the diet recommended for diabetes | 4 months | No |
| Secondary | Food Availability | questionnaire of items related to the availability in local stores of the food items recommended in the diet for diabetes. | 4 months | No |
| Secondary | Change in Waist Circumference | Measured using repeated 24 hour dietary recalls (pre and post-intervention | 4 months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
| Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
| Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
| Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
| Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
| Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |